In-person Workshop

Expert-led, 1-day program with case studies, discussions, and real-world examples.

1-Day Training

Tuesday, May 5, 2026
08:30–17:15 CST

Deadline: April 30, 2026

Hosted at:

ISCT 2026 Annual Meeting
Spencer Dock, N Wall Quay,
North Wall, Dublin 1, D01 T1W6, Ireland

Clinical CGT Immune Monitoring and Immunobiology Workshop – ISCT 2026 Dublin

As cell and gene therapies (CGT) continue to advance, standardizing immune monitoring is critical to ensure consistent patient outcomes and generate comparable data across clinical sites. The Clinical CGT Immune Monitoring and Immunobiology Workshop is a one-day, expert-led program designed for clinicians, scientists, process development associates, laboratory directors, and medical students focused on advancing CGT patient care.

Track 1 – Technical & Translational Focus: Built for process development and translational scientists. Explore fit-for-purpose assay selection, biomarker integration, workflow optimization, and practical strategies to implement standardized immune monitoring across research and clinical settings.
Track 2 – Clinical Focus: Designed for clinicians and clinical researchers. Learn novel immune monitoring strategies, implement robust biomarkers to support patient outcome prediction and follow-up, and translate immune data into actionable clinical decision-making.

Faculty will guide participants through discussions, case studies, and real-world examples, providing practical knowledge to implement and optimize immune monitoring strategies that enhance patient outcomes after CGT administration.

Special bundle pricing for this course is available with ISCT 2026 registration.

Based on past participants who attended the same Training Program
at the ISCT 2025 New Orleans Annual Meeting

87%

Said the training directly supported the learning objectives

89%

Said the program met their learning expectations

90%

Would recommend the program to a colleague

Focused on clinical CGT immune monitoring and translational application:

Foundations of immune monitoring in CAR-T and immune effector cell therapies
Selection and interpretation of biomarkers to predict clinical response
Standardizing immune monitoring workflows across clinical sites
Designing and implementing fit-for-purpose assays in CGT programs
Translating immune data into actionable clinical decision-making
Emerging technologies including multi-omics and high-throughput immune profiling

Explain the importance of immune monitoring in optimizing clinical outcomes and supporting treatment decisions
Identify and interpret biomarkers to track immune responses and predict patient outcomes
Evaluate strategies to standardize immune monitoring workflows for improved consistency and data comparability across clinical sites, including flow cytometry and pharmacokinetic assays
Apply translational immunotechnology and best practices for implementing immune monitoring in research and process development
Interpret multi-center data, understand sources of variability, and implement approaches for consistent results
Evaluate precision-enhancing assays and emerging technologies to support effective immune monitoring
Explore real-world examples to understand practical implementation and troubleshooting in immune monitoring

Track 1 — Technical / Process Development / Manufacturing Focus

Process development associates responsible for translating research into clinical applications.
Laboratory directors overseeing the implementation of new technologies and processes into existing workflows.
Quality and clinical statisticians working to harmonize clinical trials data analysis.

Track 2 — Clinical Focus

Advanced Practice Professionals (APPs), Physicians, and Early-Stage Professionals (ESPs) involved in follow-up testing and patient care after cell therapy infusions.
PhDs and MDs in translational research conducting clinical trials in cell and gene therapies, including oversight of patient outcomes.
Clinical and non-clinical scientists with an interest in immunobiology and therapeutic indications.
Laboratory professionals and support staff providing technical support in clinical research and patient monitoring.
Industry professionals from pharmaceutical and biotechnology sectors seeking a deeper understanding of clinical practices and patient follow-up to better align products and services with customer needs.

ELIGIBILITY REQUIREMENTS

None

Price (USD)

Training Course + ISCT 2025 Annual Meeting	ISCT Members	Non-Members
If you are registered for the Full Conference, attend this course for only $135.	$135
Training Course Only	ISCT Members	Non-Members
Student / Resident / Fellow / Postdoc	$175	$240
Technologist / Pharmacist / Nurse Practitioner / Nurse	$295	$425
Academia	$325	$510
Industry	$375	$560

Not an ISCT Member? Register now →

Note: If you do not see the correct rates during registration, please email us at workforcedevelopment@isctglobal.org .

For full details on our course policies, including cancellations, complaints and appeals processes and our privacy policy, click here.

The Resource Hub provides supporting materials to help reinforce learning before, during, and after the course.

Webinar title placeholder

Resource link placeholder
Resource link placeholder
Resource link placeholder

Upon Completion, You Will Receive

Certificate of Course Completion from ISCT

Note: Completing all training modules and passing the quizzes is mandatory to receive a course completion certificate.

Joint Accreditation

CME Accreditation

Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits^™ for physicians.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

What Past Participants Are Saying

“The program was well organized and directly supported the learning objectives. I found the sessions on immune monitoring processes and clinical considerations especially valuable, and I now feel more confident applying what I learned in my day-to-day role.”

Priya S.

“The workshop covered a strong mix of scientific insight and practical implementation. Topics like immune reconstitution and cutting-edge technologies were particularly engaging, and the overall experience met my expectations for a high-level training program.”

Elena V.

“I appreciated the depth of expertise from the speakers and the relevance of the material to current clinical practice. The sessions provided meaningful perspectives on immune monitoring strategies and highlighted areas that will shape future research and patient management.”

Wei L.